12Biofilms are communities of bacteria embedded in an extracellular matrix of self-13 produced polymeric substances. This polymer matrix lends the bacteria protection against 14 a wide array of chemical and mechanical stresses that they may experience in their 15 environment, which might be a location in the human body in the case of a biofilm 16 infection, or a surface immersed in fluid in an industrial setting. Breaking down the matrix 17 network renders biofilms more susceptible to physical disruption and to treatments. 18 Different species of bacteria, and different strains within the same species, produce 19 different types of matrix polymersthis suggests that targeting specific polymers for 20 disruption may be more effective than non-specific approaches to disrupting biofilm 21 matrices. In this study, we treated Pseudomonas aeruginosa biofilms with enzymes that 22 are specific to different matrix polymers. We used bulk rheology to measure the resulting 23 approaches to eradicating biofilms in environmental or industrial settings may need to be 40 very different from effective treatments of infection. 41 42 and the importance of a specific polymer type varies with biofilm-forming species and 47 strain. For biofilm infections, the matrix protects the inhabitant bacteria chemically by 48 inhibiting the diffusion of antibiotics into the biofilm and by binding to antibacterial 49 chemicals produced by the host immune response. 1-3 Furthermore, the mechanical 50 integrity and structure of the bacterial biofilm conferred by the matrix gives rise to stable 51 microenvironments that contribute to phenotypic antibiotic tolerance. 4-5 Thus, both the 52 chemical and the structural properties of the biofilm matrix contribute to bacterial 53 tolerance of harsh environments. 54Many common interventions in P. aeruginosa infections, like antibiotic treatment, 55 are far more successful if the bacteria are in a planktonic state rather than in a biofilm. 6